Loading...
New

U.S. Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care, Therapy Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Centers): Opportunity Analysis and Industry Forecast, 2020–2027

A06638
Pages: 166
Jul 2020 | 839 Views
 
Author(s) : Surabhi Pandey, Ravi Telugunta , Onkar Sumant
Tables: 50
Charts: 70
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the U.s. Advanced Wound Care Market

Request Now !

U.S. Advanced Wound Care Market Overview:

The U.S. advanced wound care market size was valued at $3.35 billion in 2019 and is expected to reach $4.97 billion by 2027, registering a CAGR of 9.9% from 2020 to 2027. 

Advanced wound care patients are at the higher risk during COVID-19 pandemic: Governments suggested providers to minimize the procedure or shift to the less risky area for the treatment. This would hamper the growth of the market during COVID-19 pandemic.

Wound healing process can be facilitated in two different ways, namely, traditional wound care (TWC) and advanced wound care (AWC). Chronic wounds take more time to heal and are expensive to treat. Thus, advanced wound care is developing as a standard solution for treating chronic wounds. Moreover, traditional wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates are increasingly being replaced with advanced wound care products, owing to their enhanced efficiency & effectiveness in managing wounds by enabling rapid healing. Moreover, they offer various advantages such as maintenance of a hydrated environment for appropriate flow of oxygen, temperature consistency, protection of wound site from exogenous infection, and ease in pain associated with dressing changes.

US-Advanced-Wound-Care-Market-2020-2027

Get more information on this report : Request Sample Pages

 

Chronic wounds are prevalent and costly to the U.S. health care system. According to a study by the Medicare beneficiaries, nearly 15% of beneficiaries have a chronic wound or infection every year, where most common chronic wounds are a result of diabetes and venous or arterial insufficiency. Furthermore, healthcare providers face major challenges in delivering care to wound patients during the COVID-19 pandemic. In addition, wound patients with multiple comorbidities are at an increased risk of infection of COVID-19.

The major factors that drive the U.S. advanced wound care market include rise in geriatric population and increase in incidences of diabetes, obesity, and chronic conditions. In addition, changes in healthcare system further drives growth of the market. However, high cost of wound care products is anticipated to hamper the market growth in the future. On the contrary, technological advancements to deal with complex wounds provide immense opportunities for market players.

U.S. Advanced Wound Care Market Segmentation 

The U.S. advanced wound care market is segmented into product, application, and end user. By product, the market is categorized into infection management, exudate management, active wound care, and therapy devices. The infection management is sub segmented into silver dressings, non-silver dressings, and collagens. The exudate management segment is further divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care segment is subdivided into skin substitutes and growth factors. The skin substitute segment is further segmented into xenograft, allografts, and cell-based bioengineering. The therapy devices segment is further segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others. Applications covered in the study include chronic wounds and acute wounds. The chronic wounds segment is further segregated into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further fragmented into burns & trauma, and surgical wounds. Depending on end user, the U.S. advanced wound care market is classified into hospitals and community health service centers.

Product segment review

On the basis product, the therapy devices segment acquired largest U.S. advanced wound care market share in 2019, owing to increase in the incidence rate of chronic diseases such as diabetes & obesity and rise in demand for innovative & advanced wound care products.

U.S. Advanced Wound Care Market
By Product

Your browser does not support the canvas element.

Therapy Devices segment holds the dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the chronic wound segment is projected to exhibit the highest CAGR during the forecast period. This is attributed to surge in prevalence of post-operative surgical wounds, rise in geriatric population, increase in awareness and improved diagnosis, and technological advancements, which has driven demand for use of advanced wound care products worldwide.

U.S. Advanced Wound Care Market
By Application

Your browser does not support the canvas element.

Chronic Wounds is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

The report provides a comprehensive analysis of the key players operating in the U.S. advanced wound care market, namely 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group Plc, Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic Plc., Organogenesis Holdings Inc., and Smith & Nephew Plc. The other players in the value chain include (profiles not included in the report) Paul Hartmann, Human Biosciences Inc., Kinetic Concept, Inc., and Mimedx Group.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current U.S. advanced wound care market trends and future estimations from 2020 to 2027, which assists in identifying the prevailing advanced wound care market opportunities. 
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
  • The key regulatory guidelines for the U.S. advanced wound care market are critically dealt across the country.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

Key Market Segments

By Product 

  • Infection Management 
    • Silver Wound Dressings
    • Non-silver Dressings
    • Collagen Dressings
  • Exudate Management 
    • Hydrocolloids Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogel Dressings
  • Active Wound Care 
    • Skin Substitutes
      • Xenograft
      • Allografts
      • Cell-based bioengineering
    • Growth Factors
  • Therapy Devices 
    • Negative Pressure Wound Therapy (NPWT)
    • Oxygen and Hyperbaric Oxygen Equipment
    • Electromagnetic Therapy Devices
    • Others

By Application

  • Chronic Wounds
  • Pressure Ulcers
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Arterial Ulcers
  • Acute Wounds
  • Burns & Trauma
  • Surgical Wounds

By End User

  • Hospitals 
  • Community Health Service Centers
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Market share analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in geriatric population
3.5.1.2.Surge in incidences of diabetes, obesity, and chronic conditions
3.5.1.3.Changes in the healthcare system

3.5.2.Restraint

3.5.2.1.High cost of advanced wound care products

3.5.3.Opportunities

3.5.3.1.Technological advancements to deal with complex wounds

3.6.Impact analysis of COVID-19 on U.S. advanced wound care market

CHAPTER 4:ADVANCED WOUND CARE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Infection management

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market size and forecast, by type
4.2.4.Silver wound dressings

4.2.4.1.Market size and forecast

4.2.5.Non-silver dressings

4.2.5.1.Market size and forecast

4.2.6.Collagen dressings

4.2.6.1.Market size and forecast

4.3.Exudate management

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by type
4.3.4.Hydrocolloid dressings

4.3.4.1.Market size and forecast

4.3.5.Foam dressings

4.3.5.1.Market size and forecast

4.3.6.Alginate dressings

4.3.6.1.Market size and forecast

4.3.7.Hydrogel dressings

4.3.7.1.Market size and forecast

4.4.Active wound care

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market size and forecast, by type
4.4.4.Skin substitutes

4.4.4.1.Market size and forecast, by type
4.4.4.2.Xenograft

4.4.4.2.1.Market size and forecast

4.4.4.3.Allografts

4.4.4.3.1.Market size and forecast

4.4.4.4.Cell-based bioengineering

4.4.4.4.1.Market size and forecast

4.4.5.Growth factors

4.4.5.1.Market size and forecast

4.5.Therapy devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by type
4.5.3.Negative pressure wound therapy (NPWT)

4.5.3.1.Market size and forecast

4.5.4.Oxygen & hyperbaric oxygen equipment

4.5.4.1.Market size and forecast

4.5.5.Electromagnetic therapy devices

4.5.5.1.Market size and forecast

4.5.6.Others

4.5.6.1.Market size and forecast

CHAPTER 5:ADVANCED WOUND CARE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Chronic wounds

5.2.1.Market size and forecast, by type
5.2.2.Pressure ulcers

5.2.2.1.Market size and forecast

5.2.3.Diabetic foot ulcers

5.2.3.1.Market size and forecast

5.2.4.Venous leg ulcers

5.2.4.1.Market size and forecast

5.2.5.Arterial ulcers

5.2.5.1.Market size and forecast

5.3.Acute wounds

5.3.1.Market size and forecast, by type
5.3.2.Burns & trauma

5.3.2.1.Market size and forecast

5.3.3.Surgical wounds

5.3.3.1.Market size and forecast

CHAPTER 6:ADVANCED WOUND CARE MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast

6.3.Community health service centers

6.3.1.Market size and forecast

CHAPTER 7:COMPANY PROFILES

7.1.3M (ACELITY INC.)

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.ADYNXX, INC.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments

7.3.B BRAUN MELSUNGEN AG

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance

7.4.COLOPLAST A/S

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.CONVATEC GROUP PLC.

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance

7.6.ESSITY AB (BSN MEDICAL GMBH)

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments

7.7.INTEGRA LIFESCIENCES (DERMA SCIENCES)

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance

7.8.INVESTOR AB (MÖLNLYCKE HEALTH CARE AB)

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance

7.9.JOHNSON & JOHNSON

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.MEDLINE INDUSTRIES, INC.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio

7.11.MEDTRONIC PLC.

7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Business performance

7.12.ORGANOGENESIS HOLDINGS INC.

7.12.1.Company overview
7.12.2.Company snapshot
7.12.3.Operating business segments
7.12.4.Product portfolio
7.12.5.Business performance

7.13.SMITH & NEPHEW PLC.

7.13.1.Company overview
7.13.2.Company snapshot
7.13.3.Operating business segments
7.13.4.Product portfolio
7.13.5.Business performance

LIST OF TABLES

TABLE 01.U.S. INCIDENCES OF DIABETES, 2011 VS. 2030 (IN MILLION)
TABLE 02.U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 03.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 04.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 05.ACTIVE WOUND CARE MARKET ADVANCED WOUND CARE, BY TYPE, 2019–2027 ($MILLION)
TABLE 06.U.S. ADVANCED WOUND CARE FOR SKIN SUBSTITUTE, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 08.U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.U.S. ADVANCED WOUND CARE MARKET FOR CHRONIC WOUND, BY TYPE, 2019–2027 ($MILLION)
TABLE 10.PRESSURE ULCER-RELATED PRODUCTS AND MANUFACTURERS
TABLE 11.U.S. ADVANCED WOUND CARE MARKET FOR ACUTE WOUND, BY TYPE, 2019–2027 ($MILLION)
TABLE 12.U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 13.3M: COMPANY SNAPSHOT
TABLE 14.3M: OPERATING SEGMENTS
TABLE 15.3M: PRODUCT PORTFOLIO
TABLE 16.ADYNXX: COMPANY SNAPSHOT
TABLE 17.ADYNXX: PRODUCT PORTFOLIO
TABLE 18.B BRAUN: COMPANY SNAPSHOT
TABLE 19.B BRAUN: OPERATING SEGMENTS
TABLE 20.B BRAUN: PRODUCT PORTFOLIO
TABLE 21.COLOPLAST: COMPANY SNAPSHOT
TABLE 22.COLOPLAST: OPERATING SEGMENTS
TABLE 23.COLOPLAST: PRODUCT PORTFOLIO
TABLE 24.CONVATEC: COMPANY SNAPSHOT
TABLE 25.CONVATEC: OPERATING SEGMENTS
TABLE 26.CONVATEC: PRODUCT PORTFOLIO
TABLE 27.ESSITY: COMPANY SNAPSHOT
TABLE 28.ESSITY: OPERATING SEGMENTS
TABLE 29.ESSITY: PRODUCT PORTFOLIO
TABLE 30.INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 31.INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 32.INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 33.INVESTOR: COMPANY SNAPSHOT
TABLE 34.INVESTOR: OPERATING SEGMENTS
TABLE 35.INVESTOR: PRODUCT PORTFOLIO
TABLE 36.J&J: COMPANY SNAPSHOT
TABLE 37.J&J: OPERATING SEGMENTS
TABLE 38.J&J: PRODUCT PORTFOLIO
TABLE 39.MEDLINE: COMPANY SNAPSHOT
TABLE 40.MEDLINE: OPERATING SEGMENTS
TABLE 41.MEDLINE: PRODUCT PORTFOLIO
TABLE 42.MEDTRONIC: COMPANY SNAPSHOT
TABLE 43.MEDTRONIC: OPERATING SEGMENTS
TABLE 44.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 45.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 46.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 47.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 48.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 49.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 50.SMITH & NEPHEW: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.U.S. ADVANCED WOUND CARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2019
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2019 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2019
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.MARKET SHARE ANALYSIS
FIGURE 12.MARKET DYNAMICS
FIGURE 13.U.S. ADVANCED WOUND CARE MARKET FOR INFECTION MANAGEMENT, 2019-2027 ($MILLION)
FIGURE 14.U.S. ADVANCED WOUND CARE MARKET FOR SILVER WOUND DRESSINGS, 2019–2027 ($MILLION)
FIGURE 15.U.S. ADVANCED WOUND CARE MARKET FOR NON-SILVER DRESSINGS, 2019–2027 ($MILLION)
FIGURE 16.U.S. ADVANCED WOUND CARE MARKET FOR COLLAGEN DRESSINGS, 2019–2027 ($MILLION)
FIGURE 17.U.S. ADVANCED WOUND CARE MARKET FOR EXUDATE MANAGEMENT, 2019-2027 ($MILLION)
FIGURE 18.U.S. ADVANCED WOUND CARE MARKET FOR HYDROCOLLOID DRESSINGS, 2019–2027 ($MILLION)
FIGURE 19.U.S. ADVANCED WOUND CARE MARKET FOAM DRESSINGS, 2019–2027 ($MILLION)
FIGURE 20.U.S. ADVANCED WOUND CARE MARKET FOR ALGINATE DRESSINGS, 2019–2027 ($MILLION)
FIGURE 21.U.S. ADVANCED WOUND CARE MARKET FOR HYDROGEL DRESSINGS, 2019–2027 ($MILLION)
FIGURE 22.U.S. ADVANCED WOUND CARE MARKET FOR ACTIVE WOUND CARE, 2019-2027 ($MILLION)
FIGURE 23.U.S. ADVANCED WOUND CARE MARKET FOR XENOGRAFT, 2019–2027 ($MILLION)
FIGURE 24.U.S. ADVANCED WOUND CARE MARKET FOR ALLOGRAFTS, 2019–2027 ($MILLION)
FIGURE 25.U.S. ADVANCED WOUND CARE MARKET FOR CELL-BASED BIOENGINEERING, 2019–2027 ($MILLION)
FIGURE 26.GROWTH FACTORS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 27.U.S. ADVANCED WOUND CARE MARKET FOR NEGATIVE PRESSURE WOUND THERAPY, 2019–2027 ($MILLION)
FIGURE 28.U.S. ADVANCED WOUND CARE MARKET FOR OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT, 2019–2027 ($MILLION)
FIGURE 29.U.S. ADVANCED WOUND CARE MARKET FOR ELECTROMAGNETIC THERAPY DEVICES, 2019–2027 ($MILLION)
FIGURE 30.OTHERS ADVANCED WOUND CARE MARKET, 2019–2027 ($MILLION)
FIGURE 31.U.S. ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, 2019–2027 ($MILLION)
FIGURE 32.U.S. ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, 2019–2027 ($MILLION)
FIGURE 33.U.S. ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, 2019–2027 ($MILLION)
FIGURE 34.U.S. ADVANCED WOUND CARE MARKET FOR ARTERIAL ULCERS, 2019–2027 ($MILLION)
FIGURE 35.U.S. ADVANCED WOUND CARE MARKET FOR BURNS & TRAUMA, 2019–2027 ($MILLION)
FIGURE 36.U.S. ADVANCED WOUND CARE MARKET FOR SURGICAL WOUNDS, 2019–2027 ($MILLION)
FIGURE 37.U.S. ADVANCED WOUND CARE MARKET FOR HOSPITALS, 2019-2027 ($MILLION)
FIGURE 38.U.S. ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS, 2020-2027 ($MILLION)
FIGURE 39.3M: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.3M: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.3M: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.B BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.B BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 44.B BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.COLOPLAST: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.COLOPLAST: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.COLOPLAST: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.CONVATEC: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.CONVATEC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.CONVATEC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.ESSITY: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.ESSITY: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.ESSITY: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54.INTEGRA LIFESCIENCES: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 56.INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 57.INVESTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.INVESTOR: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.INVESTOR: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 60.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 62.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 63.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 64.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 65.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 66.ORGANOGENESIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 67.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 68.SMITH & NEPHEW: NET SALES, 2017–2019 ($MILLION)
FIGURE 69.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 70.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)

 
 

Advanced wound care therapies function on the principle of moisture therapy. This involves keeping a wound hydrated to facilitate faster healing. In addition, they are resistant to exogenous infections, and foreign particles. 

Adoption of advanced wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates is expected to witness significant growth, owing to rise in prevalence of chronic diseases such as diabetes and obesity. In addition, these products help to maintain a steady temperature around the wound, facilitate oxygen flow, relieve pain during dressing changes, and protect wounds from infection, which further fuels their demand in healthcare settings. Moreover, rise in adoption of evidence-based treatments for chronic wounds, problems associated with traditional wound healing methods, and attempts to reduce duration of hospital stays to lower healthcare expenses fuel growth of the U.S. advanced wound care market.

Active wound care products are most popularly used in advanced wound care therapy as these products stimulate new tissue growth, control infection & pain, and facilitate supply of nutrition to wounds. These products involve substances ranging from relatively low-tech collagen to high-tech artificial growth factors that enhance wound healing process. Thus, advanced wound care products are expected to witness increased adoption, owing to rise in number of plastic surgeries. Conversely, high cost of advanced wound care products is anticipated to act as a restraint for the market. However, increase in focus toward advanced treatment protocols is expected to open new avenues for expansion of the U.S. advanced wound care market.
 

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library,  T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market value of global U.S. Advanced Wound Care market was $3.35 billion in 2019.

A. The forecast period is from 2020 to 2027.

A. The market value of global U.S. Advanced Wound Care market in 2020 is $2.57 billion.

A. The U.S. Advanced Wound Care market is expected to exhibit significant growth during the forecast period, due to the growth in geriatric population, rise in number of accidents, and increasing prevelance of diabetes, obesity, & chronic wounds across the U.S.

A. The base year is 2019 in U.S. Advanced Wound Care market

A. Based on applictaion, the chronic wounds segment held a major share in the U.S. Advanced Wound Care market in 2019 and is expected to continue the trend in the forecasting period.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
U.S. Advanced Wound Care Market

  • Data Pack
  • $2,038
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $3,249
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $3,423
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $4,774
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library.  T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts